| Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612) |
|---|
| 07/01/2010 | US20100168101 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) |
| 07/01/2010 | US20100167986 Cholesteryl Ester Transfer Protein Inhibitors |
| 07/01/2010 | CA2748250A1 Indanyl compounds |
| 06/30/2010 | EP2202216A1 Spiro-ring compound and use thereof for medical purposes |
| 06/30/2010 | EP2200975A1 Dual-acting antihypertensive agents |
| 06/29/2010 | US7745633 condensation polymerization of an effective amount of tetrazole diol or tetrazole polyol, and an isocyanate resin, and cooling to room temperature producing a linear polyurethanes; pyrotechnics; explosives and propellants and air bag gas generators |
| 06/29/2010 | US7745620 End functional groups that can covalently bind with a solid substrate or a biochemical compounds to obtain a cucurbituril; chromatographic columns, additives to gas separation membranes, catalysts, chemical, biological sensors |
| 06/24/2010 | WO2010071559A1 Processes for the manufacture of 3-{4-methyl-5- [ (ir) -1- (2- (3-methylphenyl) -2h-tetrazol-5-yl) -ethoxy] -4h- [1,2, 4] triazol-3-yl} -pyridine, 4-methyl-3-methylthio-5- (3- pyridyl)-l,2,4-triazole, and (ir) -1- [2- (3-methylphenyl) -2h- tetrazol-5-yl] ethanol |
| 06/24/2010 | WO2009106470A3 Angiotensin ii receptor antagonists |
| 06/24/2010 | US20100160643 Process for Preparing Trityl Olmesartan Medoxomil and Olmesartan Medoxomil |
| 06/24/2010 | US20100160343 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 06/24/2010 | US20100160341 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 06/22/2010 | US7741492 Method for obtaining a pharmaceutically active compound (Irbesartan) and its synthesis intermediate |
| 06/22/2010 | US7741354 Neuroproptective drug; Parkinson's disease; immunomoderators; enzyme inhibitors; immunosuppressants; antihistamines; alzheimer's disease; Down's syndrome; Huntington disease |
| 06/22/2010 | US7741353 Lead-free primary explosives |
| 06/22/2010 | US7741352 for the treatment or alleviation of pain, headaches, nervous system disorders or trauma, stroke, neurodegenerative diseases, cardiovascular disorders, inflammatory diseases, vision defects, hearing disorders, respiratory system disordres and urinary incontinence |
| 06/22/2010 | US7741328 Treating inflammatory diseases such as rheumatoid arthritis, multiple sclerosis or Crohn's disease; Very Late Antigen-4 (VLA-4), also called alpha 4 beta 1 integrin; N-(sulfonamido-substituted pyrimidyl, pyridyl or pyrazyl)-L-4-(N,N-dimethylcarbamyloxy)phenylalanine compounds |
| 06/17/2010 | WO2010067913A1 Method of removing the triphenylmethane protection group |
| 06/17/2010 | US20100152458 Coupling reactions useful in the preparation of (1h-tetrazol-5-yl) biphenyl derivatives |
| 06/17/2010 | US20100152045 Phenylalkyl Substituted Heteroaryl Derivatives |
| 06/17/2010 | US20100150836 Radiolabelled benzamide analogues, their synthesis and use in diagnostic imaging |
| 06/16/2010 | CN101735164A Method for researching and controlling impurity F in valsartan |
| 06/16/2010 | CN101735106A Method for preparing biphenyl compound |
| 06/16/2010 | CN101157660B Dibenz tetraaza [14] annulene compound and preparation method and application thereof |
| 06/15/2010 | US7737272 Diazaphosphacycle transition metal complexes |
| 06/10/2010 | WO2010065432A1 Nitrooxy derivatives as angiotensin ii receptor antagonists |
| 06/10/2010 | WO2010063724A1 Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases |
| 06/10/2010 | US20100144810 Angiotensin ii receptor antagonists |
| 06/10/2010 | US20100144809 Novel benzamidine derivatives useful as potassium channel modulators |
| 06/10/2010 | US20100144736 Novel biphenyl thio-urea derivatives useful as potassium channel modulators |
| 06/10/2010 | CA2745252A1 Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases |
| 06/10/2010 | CA2745095A1 Nitrooxy derivatives as angiotensin ii receptor antagonists |
| 06/09/2010 | EP2194050A1 A new process for the preparation of irbesartan |
| 06/09/2010 | EP2194048A1 Nitrate esters for the treatment of vascular and metabolic diseases |
| 06/03/2010 | US20100137600 Photogenerated reagents |
| 06/03/2010 | US20100137444 Ketone compounds and compositions for cholesterol management and related uses |
| 06/03/2010 | US20100137388 Therapeutic Pro-Antibiotic Agents and Methods of Use Thereof |
| 06/03/2010 | US20100137387 Beta-keto-amide derivatives useful as ion channel modulators |
| 06/03/2010 | US20100137381 Acetamide derivatives as potassium channel modulators |
| 06/03/2010 | US20100137327 Novel semicarbazide and carbonylhydrazide derivatives useful as potassium channel modulators |
| 06/03/2010 | CA2744021A1 Nitrooxy cycloalkane derivatives |
| 06/02/2010 | EP1658263B1 Novel aminobenzophenone compounds |
| 06/02/2010 | CN1805942B Diphenylurea derivatives and their use as chloride channel blockers |
| 06/02/2010 | CN1712404B Purification of porphyrin medicine |
| 06/01/2010 | US7728024 Metal salts of 2′-(1H-Tetrazol-5yl)-1.1′-biphenyl-4-carboxaldehyde |
| 06/01/2010 | US7728023 Respiratory system disorders; leukotriene receptor antagonists; asthma, chronic obstructive pulmonary disease, pulmonary emphysema, chronic bronchitis, pneumonia; 1-(3-carboxypropyl)-4-{(E)-2-[4-(4-phenylbutoxy)phenyl]vinyl}-1H-indole-3-carboxylic acid |
| 06/01/2010 | US7728021 Process for the preparation of Valsartan and precursors thereof |
| 06/01/2010 | US7727997 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/27/2010 | US20100130737 Regulating Agent of GPR34 Receptor Function |
| 05/27/2010 | US20100130509 Novel antibiotics |
| 05/25/2010 | US7723529 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-5-[(3-(nitrooxy) propyl)carbonyloxy]methyl-1H-imidazole |
| 05/25/2010 | US7723380 Tetrahydrofuro[2,3-b]furyl carbamates containing an (oxy)hydrazide group; these compounds target the HIV protease in both wild type and mutant strains of HIV. |
| 05/25/2010 | US7723367 Amino-tetrazoles analogues and methods of use |
| 05/25/2010 | US7723362 for controlling acarina |
| 05/20/2010 | WO2010056527A2 Fused heterocyclic compounds as ion channel modulators |
| 05/20/2010 | WO2010056205A1 Intravascular contrast agents |
| 05/20/2010 | WO2010055207A1 Chelating, chelating agents and conjugates deriver thereof |
| 05/20/2010 | WO2010055005A1 Naphthylacetic acids |
| 05/20/2010 | CA2740864A1 Naphthylacetic acids |
| 05/19/2010 | EP1706372B1 Alpha-hydroxy amides as bradykinin antagonists or inverse agonists |
| 05/13/2010 | US20100121072 Candesartan cilexetil polymorphs |
| 05/13/2010 | US20100120874 Heterocyclic gamma secretase modulators |
| 05/13/2010 | US20100120784 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 05/12/2010 | CN1867336B 1-aryl-4-substituted piperazines derivatives and pharmaceutical use thereof |
| 05/06/2010 | US20100113798 Process for preparation of irbesartan |
| 05/06/2010 | US20100113449 Fused heterocyclic compounds as ion channel modulators |
| 05/05/2010 | CN1914356B Surface-treating agent for metal |
| 05/04/2010 | US7709655 Clickphosphines for transition metal-catalyzed reactions |
| 05/04/2010 | US7709486 antiviral compounds 1,4,8,11-tetraazacyclotetradecane derivatives for against HIV-infected cells, to inhibit the binding by the natural ligand to its chemokine receptor; viricides |
| 05/04/2010 | CA2320467C Cycloalkene derivatives, their production and use |
| 04/29/2010 | US20100105894 Cyclopropane compounds and pharmaceutical use thereof |
| 04/29/2010 | US20100105689 Novel 1,4- and 1,5-diarylsubstituted 1,2,3-triazoles useful as potassium channel modulators |
| 04/29/2010 | US20100105683 Compounds useful for inhibiting chk1 |
| 04/28/2010 | EP2179984A1 Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition |
| 04/28/2010 | EP1678162B1 P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same |
| 04/27/2010 | US7705177 t-Butyl 1-[9-[1-(tert-butoxycarbonyl)cyclopropyl]-5-oxononyl]-1-cyclopropanecarboxylate; Alzheimer's Disease, Syndrome X, peroxisome proliferator activated receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis, hypertension, renal disease, cancer, inflammation, impotence |
| 04/27/2010 | US7705026 Biaryl heterocyclic compounds and methods of making and using the same |
| 04/27/2010 | US7704997 Amino-tetrazole analogues and methods of use |
| 04/27/2010 | CA2345118C Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 04/22/2010 | WO2010043000A1 S1p receptors modulators and their use thereof |
| 04/22/2010 | WO2010012442A3 Insecticidal benzenedicarboxamide derivative |
| 04/22/2010 | WO2010009879A3 Methods for producing paricalcitol |
| 04/22/2010 | US20100099649 Site-specific chemical modification of proteins at their n-termini, enabling the formation of homogeneous adducts |
| 04/22/2010 | CA2740484A1 S1p receptors modulators and their use thereof |
| 04/21/2010 | CN1923820B Novel carboxylic acid derivatives, their preparation and use |
| 04/20/2010 | US7700784 angiotension II receptor antagonists or AT1 receptor antagonists |
| 04/20/2010 | US7700586 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 04/20/2010 | CA2494067C Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 04/20/2010 | CA2361587C Methods and compositions to enhance white blood cell count |
| 04/20/2010 | CA2319680C Compounds and compositions for delivering active agents |
| 04/20/2010 | CA2279331C Compounds and compositions for delivering active agents |
| 04/15/2010 | WO2010041748A1 Fluorene compound and use thereof for medical purposes |
| 04/15/2010 | WO2010022249A3 Macrocyclic compounds for inhibition of tumor necrosis factor alpha |
| 04/14/2010 | EP1694410B1 Cyclopropane derivatives and pharmaceutical use thereof |
| 04/14/2010 | EP1551799B1 Cyclohexyl sulphones as gamma-secretase inhibitors |
| 04/14/2010 | EP1294922B1 Treating cancer using organelle crystallizing agents |
| 04/13/2010 | USRE41226 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 04/13/2010 | US7696358 Five-membered heterocyclyl tetracycline compounds and methods of use thereof |
| 04/13/2010 | US7696231 Therapy, prevention of metabolism disorders; insulin resistance; antidiabetic agents; hypoglycemic agents; anticholesterol agents; obesity; polycystic ovarian syndrome |
| 04/13/2010 | CA2531573C Alkoxy-(tetrazol-1-yl)benzaldehyde compound and process for producing the same |